/PRNewswire/ -- CS Genetics, a privately held genomics technology company, today announced the commercial launch of its 96-sample SimpleCell 3' Gene Expression Kit, further expanding the capabilities of its SimpleCell platform for scalable, cost-efficient single cell RNA sequencing.

/PRNewswire/ -- 私营基因组学技术公司CS Genetics今日宣布推出其96样本SimpleCell 3'基因表达试剂盒的商业化版本，进一步扩展了其SimpleCell平台在可扩展、经济高效的单细胞RNA测序方面的能力。

This new high-throughput format joins the existing 8- and 16-sample kits, giving researchers unmatched flexibility to scale their studies from exploratory pilot experiments to large cohort or population-scale designs.

这种新的高通量格式加入了现有的8样本和16样本试剂盒，使研究人员能够无与伦比地灵活扩展他们的研究，从探索性初步实验到大型队列或群体规模设计。

96-Sample SimpleCell 3' Gene Expression Kit is now commercially available

96样品SimpleCell 3'基因表达试剂盒现已上市销售

'With the 96-sample kit, we're enabling a new tier of throughput and efficiency in single cell genomics,' said

‘通过96样本试剂盒，我们正在实现单细胞基因组学中新的通量和效率水平，’

Bill Colston

比尔·科尔斯顿

, PhD, CEO of CS Genetics. 'This launch marks a major milestone in our mission to make high-resolution biology accessible at scale.'

博士，CS Genetics首席执行官。 “此次发布标志着我们在大规模实现高分辨率生物学可及性的使命中迈出了重要的里程碑。”

A New Standard for Throughput in Single Cell Studies

单细胞研究中吞吐量的新标准

Designed to simplify and streamline large experiments, the new 96-sample kit allows researchers to:

旨在简化和优化大型实验，新的96样本试剂盒使研究人员能够：

Process up to 96 independent samples in parallel with a single kit

使用单一试剂盒并行处理多达96个独立样本

Maintain data consistency and quality across large experimental designs

在大型实验设计中保持数据一致性和质量

Significantly reduce per-sample cost and processing time

显著降低每次采样的成本和处理时间

The SimpleCell platform continues to stand out for its instrument-free, same-day workflow, compatibility with standard lab equipment, and exceptional data quality. With the added throughput of the 96-sample kit, SimpleCell is now well-suited for a new generation of large-scale studies, including high-throughput screening, multi-condition assays, and AI-driven discovery workflows that rely on rich and scalable single cell datasets..

SimpleCell平台因其无需仪器、当日完成的工作流程、与标准实验室设备的兼容性以及卓越的数据质量而继续脱颖而出。随着96样本试剂盒的加入，SimpleCell现在非常适合新一代大规模研究，包括高通量筛选、多条件检测和依赖丰富且可扩展的单细胞数据集的AI驱动发现工作流程。

'Large-scale 'omics' technologies have long been a cornerstone of our work with the 120,000+ pediatric biobank collection at the Center for Applied Genomics (CAG),' said Hákon Hákonarson, MD, PhD, Director of the CAG at the Children's Hospital of Philadelphia. 'We're excited about the potential of the 96-sample SimpleCell kit, which could be truly transformative by enabling us to generate high-quality single cell data across diverse sample sets more efficiently and at significantly lower cost, especially when integrated with our existing automation workflows.'.

“大规模的‘组学’技术长期以来一直是我们利用应用基因组学中心 (CAG) 拥有的超过12万名儿童生物样本库的核心方法，”费城儿童医院CAG主任Hákon Hákonarson医学博士表示，“我们对96样本SimpleCell试剂盒的潜力感到兴奋，它可能通过使我们能够更高效地在各类样本集中生成高质量的单细胞数据，并且成本显著降低，特别是在与我们现有的自动化工作流程结合时，带来真正的变革。”

Availability

可用性

The SimpleCell 96-sample 3' Gene Expression Kit is now available for commercial order. To learn more or request a quote, visit

SimpleCell 96样本3'基因表达试剂盒现已开放商业订购。如需了解更多信息或索取报价，请访问

About CS Genetics

关于CS遗传学

CS Genetics is a privately held genomics-technology company based in San Diego,

CS Genetics 是一家总部位于圣地亚哥的私有基因组学技术公司，

California

加利福尼亚州

. The company has developed a radically new, instrument-free platform for single-cell genomics with disruptive simplicity, speed, and scalability that will launch a new era of NGS-based cellular analysis. The company's technology leverages a molecular process known as Kinetic Confinement that is categorically different to other single cell technologies, and plugs seamlessly into standard, widespread lab infrastructure.

公司开发了一种全新的、无需仪器的单细胞基因组学平台，具有颠覆性的简便性、速度和可扩展性，将开启基于新一代测序（NGS）的细胞分析新时代。该公司的技术利用了一种称为动力学限制的分子过程，这一过程在类别上与其他单细胞技术不同，并且能够无缝接入标准、广泛使用的实验室基础设施。

The company holds a large global intellectual property estate covering its single cell platform and related reagent, workflow, manufacturing and application technologies. For more information, visit .

该公司拥有涵盖其单细胞平台及相关试剂、工作流程、制造和应用技术的大型全球知识产权资产。欲了解更多信息，请访问。